Clavister: Operational Improvements
Redeye leaves valuation unchanged on the back of a stable Q1, the key take-away of which were cash-flow improvements, +85% gross margins and a lower than expected EBIT-loss. Our current-year forecasts (including growth of 20%) should lend support to the stock if they materialize.